CDC seeks bird flu diagnostic tests

Dec 05, 2006

The U.S. Centers for Disease Control and Prevention has awarded $11.4 million for development of new, rapid diagnostic tests for avian influenza.

The CDC said the contracts went to four companies working to develop diagnostic tests that physicians and field epidemiologists could use to quickly and accurately test patients for avian influenza H5N1 and other emerging viruses, receiving results within 30 minutes.

In providing the funding, the CDC said it hopes commercialization of the products can occur within two to three years.

Existing point-of-care tests can only determine if the patient is infected with seasonal influenza viruses A or B, but cannot identify avian influenza H5N1. To test for H5N1, patient samples currently must be sent to one of about 100 designated labs nationwide that can perform specialized testing. The process can take four to 24 hours to complete, depending on shipping of samples.

The companies receiving CDC funding are Cepheid Inc. of Sunnyvale, Calif.; Iquum Inc. of Marlborough, Mass.; MesoScale Discovery of Gaithersburg, Md.; and Nanogen Inc. of San Diego.

Copyright 2006 by United Press International

Explore further: Head of troubled CDC anthrax lab has resigned

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Diseases of another kind

45 minutes ago

The drought that has the entire country in its grip is affecting more than the color of people's lawns. It may also be responsible for the proliferation of a heat-loving amoeba commonly found in warm freshwater bodies, such ...

Meningitis diagnosis prompted W.Va. clinic probe

Jul 22, 2014

A health official says an investigation that found syringes were being reused at a West Virginia pain management clinic was triggered by patient who developed bacterial meningitis.

User comments : 0